Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $707M bought by 129 insiders at 88 companies
- $1.3B sold by 84 insiders outside a trading plan
- $1B sold by 338 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$12.6M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Chi-Hong Ju Senior VP, Systems & GMAMBAAmbarella, Inc.Sale$130K 2,009 shares at $64.83 1.3% of stakeTraded Sep 17 Filed Sep 18
-
Chan W Lee Chief Operations OfficerAMBAAmbarella, Inc.Sale$188K 2,893 shares at $64.83 1.8% of stakeTraded Sep 17 Filed Sep 18
-
John Alexander Young CFOAMBAAmbarella, Inc.Sale$203K 3,126 shares at $64.83 2.8% of stakeTraded Sep 17 Filed Sep 18
-
Dietmar Ostermann DirectorXOSXos, Inc.Sale$13K 5,000 shares at $2.55 5.5% of stakeTraded Sep 16–17 Filed Sep 18
-
Kumar Budur Chief Medical OfficerHRMYHarmony Biosciences Holdings, Inc.Planned sale$1.7M 38,452 shares at $43.05 75% of stakeTraded Sep 16–18 Filed Sep 18
-
Masatoshi Koide Pres. and Rep. Director, ALIJAFLAflac IncorporatedSale$1.6M 13,201 shares at $118.01 15% of stakeTraded Sep 16 Filed Sep 18
-
Martha Cummings DirectorMQMarqeta, Inc.Planned sale$11K 713 shares at $16.01 6.2% of stakeTraded Sep 16 Filed Sep 18
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.2M 64,000 shares at $97.49 12% of stakeTraded Sep 17–18 Filed Sep 18
-
Robert Robotti DirectorTDWTidewater Inc.Sale$925K 10,300 shares at $89.85 0.5% of stakeTraded Sep 16 Filed Sep 18
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $496.06 2.8% of stakeTraded Sep 17 Filed Sep 18
-
John R. Furner CEOWMTWalmart Inc.Planned sale$1.4M 13,125 shares at $106.66 2% of stakeTraded Sep 17 Filed Sep 18
-
Paul A Mahon EVP & General CounselUTHRUnited Therapeutics CorporationPlanned sale$4.1M 8,300 shares at $497.54 16% of stakeTraded Sep 17 Filed Sep 18
-
Samak L Azar Chief Legal OfficerGFSGlobalFoundries Inc.Planned sale$15K 335 shares at $44.87 3.4% of stakeTraded Sep 17 Filed Sep 18
-
Edward Carr Chief Accounting OfficerDNTHDianthus Therapeutics, Inc.Planned sale$2M 20,000 shares at $101.38 100% of stakeTraded Sep 17 Filed Sep 18
-
Christopher James Nicholas Executive Vice PresidentWMTWalmart Inc.Planned sale$309K 2,900 shares at $106.65 0.5% of stakeTraded Sep 17 Filed Sep 18
-
Sl Spv-2, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$26.7M 46,994 shares at $567.88 34% of stakeTraded Sep 16 Filed Sep 18
-
Silver Lake Partners IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$32.3M 56,794 shares at $567.89Traded Sep 16 Filed Sep 18
-
Silver Lake Technology Investors IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$599K 1,054 shares at $567.88 100% of stakeTraded Sep 16 Filed Sep 18
-
Silver Lake Technology Investors V, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$270K 475 shares at $567.89 100% of stakeTraded Sep 16 Filed Sep 18
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$7.8M 500,000 shares at $15.55 6.2% of stakeTraded Sep 16–17 Filed Sep 18
-
Silver Lake Partners V DE (AIV), L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$15.3M 26,985 shares at $567.88 36% of stakeTraded Sep 16 Filed Sep 18
-
Simon Heidi Locke DirectorTKTeekay Corporation Ltd.Sale$5,972 400 shares at $14.93 0.9% of stakeTraded Sep 17 Filed Sep 18
-
Julien Wetterwald Chief Technology OfficerWLTHWealthfront CorporationPlanned sale$264K 26,138 shares at $10.10 3.6% of stakeTraded Sep 17 Filed Sep 18
-
Richard M Schulze InsiderBBYBest Buy Co., Inc.Sale$27.8M 300,000 shares at $92.51 100% of stakeTraded Sep 16 Filed Sep 18
-
Jamie L. Reynoso CEO, Medicare AdvantageCLOVClover Health Investments, Corp.Planned sale$8,760 1,921 shares at $4.56 0.1% of stakeTraded Sep 17 Filed Sep 18
-
Lauren Lin CLO, CCO and SecretaryWLTHWealthfront CorporationPlanned sale$46K 4,574 shares at $10.10 2.6% of stakeTraded Sep 17 Filed Sep 18
-
Kal Iyer VP, EngineeringWLTHWealthfront CorporationPlanned sale$270K 26,738 shares at $10.11 10% of stakeTraded Sep 17 Filed Sep 18
-
Craig C MacKay DirectorEQHEquitable Holdings, Inc.Sale$109K 2,000 shares at $54.28 11% of stakeTraded Sep 17 Filed Sep 18
-
Alan Imberman CFOWLTHWealthfront CorporationPlanned sale$773K 76,540 shares at $10.10 16% of stakeTraded Sep 17 Filed Sep 18
-
Masaru Matsuda See RemarksARQTArcutis Biotherapeutics, Inc.Planned sale$92K 3,674 shares at $25.00 3.2% of stakeTraded Sep 16 Filed Sep 18
-
Oluyemi Okupe CFOHIMSHims & Hers Health, Inc.Planned sale$355K 12,313 shares at $28.82 4.7% of stakeTraded Sep 17 Filed Sep 18
-
David Fortunato CEOWLTHWealthfront CorporationPlanned sale$1M 100,000 shares at $10.14Traded Sep 17 Filed Sep 18
-
Kristopher Hanson General CounselMPLTMapLight Therapeutics, Inc.Planned sale$193K 16,509 shares at $11.67 11% of stakeTraded Sep 16 Filed Sep 18
-
Thomas Russell Chief Legal OfficerGENIGenius Sports LimitedSale$326K 50,000 shares at $6.51 9.6% of stakeTraded Sep 17 Filed Sep 18
-
Norman P Taffe President Generac HomeGNRCGenerac Holdings Inc.Planned sale$34K 150 shares at $229.50 1.3% of stakeTraded Sep 17 Filed Sep 18
-
Christopher Ryan Sullivan CFOAVTXAvalo Therapeutics, Inc.Planned sale$202K 12,394 shares at $16.33 24% of stakeTraded Sep 16 Filed Sep 18
-
Mukul Kumar President, EngineeringPUBMPubMatic, Inc.Planned sale$134K 8,000 shares at $16.78 6.6% of stakeTraded Sep 16 Filed Sep 18
-
Kyle Andrew Raabe President, Home Power Gen.GNRCGenerac Holdings Inc.Planned sale$138K 603 shares at $229.50 5.5% of stakeTraded Sep 17 Filed Sep 18
-
Darren S Raiguel COOPLUSePlus inc.Planned sale$13K 139 shares at $93.38 0.2% of stakeTraded Sep 16 Filed Sep 18
-
Mauad Bruno Sousa DirectorAUGOAura Minerals Inc.Sale$6.8M 73,925 shares at $92.40 86% of stakeTraded Sep 17 Filed Sep 18
-
Paul Caine DirectorMGNIMagnite, Inc.Planned sale$199K 7,500 shares at $26.50 5.2% of stakeTraded Sep 17 Filed Sep 18
-
Phyllis B Nordstrom CFODDD3D Systems CorporationSale$107K 30,000 shares at $3.58 4% of stakeTraded Sep 17 Filed Sep 18
-
Lingke Wang PresidentLIFEEthos Technologies Inc.Planned sale$4.6M 118,333 shares at $38.96 7.1% of stakeTraded Sep 17 Filed Sep 18
-
Peter George Colis CEOLIFEEthos Technologies Inc.Planned sale$2.7M 70,000 shares at $38.51 4.4% of stakeTraded Sep 16–18 Filed Sep 18
-
Kathleen Goin COOPVLAPalvella Therapeutics, Inc.Planned sale$655K 4,302 shares at $152.24 100% of stakeTraded Sep 16 Filed Sep 18
-
Tajinder S Vohra Please See RemarksRVTYRevvity, Inc.Planned sale$1M 7,330 shares at $140.88 53% of stakeTraded Sep 16 Filed Sep 18
-
Douglas S Knopper DirectorMGNIMagnite, Inc.Planned sale$981K 37,337 shares at $26.28 42% of stakeTraded Sep 17 Filed Sep 18
-
Jeffrey A Graves CEODDD3D Systems CorporationSale$152K 42,686 shares at $3.55 3.3% of stakeTraded Sep 17 Filed Sep 18
-
Daniel Schumacher CFOPRLBProto Labs, Inc.Planned sale$426K 5,000 shares at $85.21 11% of stakeTraded Sep 16–17 Filed Sep 18
-
Rodolpho C Cardenuto DirectorSMTCSemtech CorporationSale$878K 5,321 shares at $165.00 100% of stakeTraded Sep 16 Filed Sep 18
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.